Zobrazeno 1 - 10
of 62
pro vyhledávání: '"C, de Gislain"'
Autor:
Michèle Delaunay, Peter Mohr, M Mousseau, J.R Bensadoun, Axel Hauschild, C de Gislain, Didier Cupissol, B.B Nguyen, Bernard Guillot, F Mornex, Thierry Lesimple, Luc Thomas, Jacques Bonneterre, Jens Ulrich, S Bourdin, M Clavel, Wolfgang Tilgen
Publikováno v:
Cancer/Radiothérapie. 7:1-8
Resume Objectif de l'etude. – L'objectif de cette etude prospective, multicentrique et randomisee de phase III etait de comparer l'association de la fotemustine et d'une irradiation encephalique totale a la fotemustine seule en termes de reponse ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55f9618f4061fb354599faea831d8c04
https://doi.org/10.1016/s1278-3218(02)00284-6
https://doi.org/10.1016/s1278-3218(02)00284-6
Autor:
Gilles Calais, P. Clavère, P. Maillart, Thierry Delozier, Moïse Namer, J.L Wendling, P.L Etienne, C. de Gislain, F. Turpin, Gérard Ganem, Elisabeth Luporsi, D Tigaud, Daniel Serin, Gilles Romieu, G. Prévost, Simon Schraub, P Marti, P Chinet-Charrot, Jean-Christophe Eymard, P. Colin, P Soler-Michel, Pierre Pouillart, Véronique Trillet-Lenoir
Publikováno v:
European Journal of Cancer. 37:1132-1140
This comparative phase III trial of mitoxantrone+vinorelbine (MV) versus 5-fluorouracil+cyclophosphamide+either doxorubicin or epirubicin (FAC/FEC) in the treatment of metastatic breast cancer was conducted to determine whether MV would produce equiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6d6841c80c8c7a85604f58a507d08d8
https://doi.org/10.1016/s0959-8049(01)00093-4
https://doi.org/10.1016/s0959-8049(01)00093-4
Autor:
F, Mornex, L, Thomas, P, Mohr, A, Hauschild, M M, Delaunay, T, Lesimple, W, Tilgen, B B, Nguyen, B, Guillot, J, Ulrich, S, Bourdin, M, Mousseau, D, Cupissol, J, Bonneterre, C, de Gislain, J R, Bensadoun, M, Clavel
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 7(1)
The main objective of this prospective multicenter randomised phase III study was to compare a combined regimen of fotemustine plus whole brain irradiation versus fotemustine alone in terms of cerebral response and time to cerebral progression in pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0653c64d6f65a4d621b69b5ee261fd82
https://pubmed.ncbi.nlm.nih.gov/12648711
https://pubmed.ncbi.nlm.nih.gov/12648711
Autor:
Luc Thomas, Peter Mohr, B N Bui, R J Bensadoun, C de Gislain, Wolfgang Tilgen, Michèle Delaunay, Jens Ulrich, Didier Cupissol, M Clavel, S Bourdin, F Mornex, M Mousseau, Axel Hauschild, Thierry Lesimple, M E Bonneterre, Bernard Guillot
Publikováno v:
Melanoma research. 13(1)
The main objective of this prospective multicentre randomized phase III study was to compare a combined regimen of fotemustine plus whole brain irradiation with fotemustine alone in terms of cerebral response and time to cerebral progression in patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e26e7b35c901395233dc13f61e17a056
https://pubmed.ncbi.nlm.nih.gov/12569292
https://pubmed.ncbi.nlm.nih.gov/12569292
Autor:
B, Cutuli, M, Janvier, A, de la Rochefordière, J P, Julien, N, Isambert, C, Alzieu, P, Kerbrat, B, de Lafontan, L, van Lemmens, H, Curé, G, Ganem, D, Baume, A, Le Mevel, A, Lorthoraly, C, de Gislain, C, Marchal, C, Chevelle, H, Lauche, D, Serin
Publikováno v:
Presse medicale (Paris, France : 1983). 29(3)
The purpose of this study was to determine the clinical and prognostic features of leukemias and preleukemic states, whatever the mode of development, observed in patients after treatment of breast cancer.A retrospective multicentric analysis was mad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7191f51352604159afb6a32a8e142440
https://pubmed.ncbi.nlm.nih.gov/10686962
https://pubmed.ncbi.nlm.nih.gov/10686962
Autor:
H, Mignotte, C, Lasset, V, Bonadona, A, Lesur, E, Luporsi, J F, Rodier, B, Cutuli, S, Lasry, L, Mauriac, C, Granon, C, Kerr, S, Giard, C, Hill, B, de Lafontan, C, de Gislain, J, D'Anjou, E, Fondrinier, C, Lefeuvre, R M, Parache, F, Chauvin
Publikováno v:
International journal of cancer. 76(3)
Since tamoxifen is widely used in breast cancer treatment and has been proposed for the prevention of breast cancer, its endometrial iatrogenic effects must be carefully examined. We have investigated the association between endometrial cancer and ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1b7a3c1b3de9a1a0e4b0c0c59252768e
https://pubmed.ncbi.nlm.nih.gov/9579567
https://pubmed.ncbi.nlm.nih.gov/9579567
Autor:
P, Cappelaere, C, Fournier, F, Rolland, L, Meeus, C, Domenge, I, Krakowski, C, De Gislain, J, Chauvergne, F, Dufour-Esquerre, J M, Pion, B, Hecquet
Publikováno v:
Bulletin du cancer. 83(7)
The aim of this study was to determine the value of haematological counts at the 4th day of a chemotherapy cycle, in order to foresee neutro and/or thrombocytopenia during the same chemotherapy cycle. One hundred and ten cycles of chemotherapeutic re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5809c587bef286fbc0225cc6ab2cbebe
https://pubmed.ncbi.nlm.nih.gov/8868944
https://pubmed.ncbi.nlm.nih.gov/8868944
Autor:
E. Gamelin, T. Le Simple, Jean-Marie Dilhuydy, J. Berlie, C. de Gislain, T.D. N'Guyen, B. De Lafontan, V. Moncho-Bernier, M. Hery, Bruno Cutuli, J. Tortochaux, Y. Graic, M. Lacroze, François Campana, François Lesaunier, M. Resbeut, M. Reme-Saumon, J.C. Cuillere, Christian Marchal, M. Veiten
Publikováno v:
European journal of cancer (Oxford, England : 1990). (12)
From 1960 to 1986, 397 cases of non-metastatic male breast cancer (MBC) treated in 14 French regional cancer centres were reviewed. The median age was 64 years (range 25-93). TNM classification (UICC, 1978) showed seven T0, 79 T1, 162 T2, 31 T3, 74 T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1c4b3db701428e201b186f500aa0f81
https://pubmed.ncbi.nlm.nih.gov/8562148
https://pubmed.ncbi.nlm.nih.gov/8562148
Autor:
P, Cappelaere, B, Hecquet, F, Rolland, L, Meeus, C, Domenge, I, Krakowski, C, De Gislain, J, Chauvergne, F, Dufour-Esquerré, P, Carde
Publikováno v:
Bulletin du cancer. 82(9)
Eighty-four patients with locally advanced, non metastatic squamous cell carcinoma of head and neck or esophagus, were included in a multicentric double-blind randomized trial, comparing goralatide (12.5 or 62.5 micrograms/kg/day, d1-d4) to placebo,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::140a102674d5d8d2085d4e2740c5704b
https://pubmed.ncbi.nlm.nih.gov/8535033
https://pubmed.ncbi.nlm.nih.gov/8535033
Publikováno v:
Cancer Treatment An Update ISBN: 9782817807676
From the 1st June 1975 to 1st March 1990 a hundred patients with locally advanced carcinoma of the breast were treated with Neo-Adjuvant chemotherapy. The mean age of our group was 50.7 years (median 49 years, range 23–71 years). 60 % of the patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29f5a4fb338a922804aad490175d9ff3
https://doi.org/10.1007/978-2-8178-0765-2_22
https://doi.org/10.1007/978-2-8178-0765-2_22
